Advanced Clinical Guide for GCC Healthcare Professionals
Where pKa = 6.1, [HCO3-] in mEq/L, PaCO2 in mmHg. This describes the relationship between the metabolic and respiratory components of acid-base balance. The ratio [HCO3-] / (0.03 × PaCO2) determines pH direction.
CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3-. Most important buffer in ECF. Regulated by lungs (CO2) and kidneys (HCO3-).
HPO4²- + H+ ⇌ H2PO4-. Important in renal tubules and intracellular fluid. pKa ~6.8.
Amino acid side chains act as H+ acceptors/donors. Accounts for ~70% of non-bicarbonate buffering in blood.
Deoxyhaemoglobin is a better buffer than oxyhaemoglobin (Haldane effect). Critical in red blood cells during CO2 transport.
Responds within minutes. Changes in RR/TV alter PaCO2. Chemoreceptors detect pH changes and adjust ventilation.
Responds over 3–5 days. Kidneys regulate HCO3- by reabsorption/excretion and H+ excretion via ammoniagenesis and titratable acids.
The Stewart model provides a physicochemical framework for acid-base analysis beyond the traditional HH approach.
Normal SID ≈ 40–44 mEq/L. When SID falls (e.g. hyperchloraemia), acidosis results. When SID rises, alkalosis results. This explains why normal-AG hyperchloraemic acidosis occurs with saline infusion (dilution of SID) and helps identify complex ICU acid-base disorders not explained by traditional approach.
Most enzymes have optimal pH 7.35–7.45. Acidosis/alkalosis denatures proteins and impairs metabolic reactions.
Acidosis → right shift (Bohr effect) → reduced O2 binding but increased O2 release to tissues. Alkalosis → left shift → increased affinity but poor release.
pH affects drug ionisation (Henderson-Hasselbalch). Acidosis increases absorption of weak acids; alkalosis increases excretion. Critical for salicylate/tricyclic overdose.
Acidosis → hyperkalaemia (K+ moves out of cells). Alkalosis → hypokalaemia. Each 0.1 pH unit change → ~0.6 mEq/L K+ shift inversely.
Severe acidosis (pH <7.1) depresses myocardial contractility, causes arrhythmias, and reduces response to catecholamines.
Alkalosis → cerebral vasoconstriction → tetany/seizures. Acidosis → cerebral vasodilation; CO2 crosses BBB readily.
Alveolar hypoventilation leads to CO2 retention → carbonic acid accumulation → acidosis.
| Category | Examples |
|---|---|
| Obstructive lung | COPD exacerbation, severe asthma |
| Obesity/Restrictive | Obesity hypoventilation syndrome (OHS) |
| Neuromuscular | GBS, MG crisis, ALS, phrenic nerve palsy |
| CNS depression | Opioids, benzodiazepines, anaesthetic agents |
| Thoracic | Flail chest, massive pleural effusion, kyphoscoliosis |
| Airway obstruction | Foreign body, severe OSA |
Alveolar hyperventilation → CO2 washout → reduced carbonic acid → alkalosis.
| Category | Examples |
|---|---|
| Psychogenic | Anxiety, panic attacks, pain |
| Hypoxaemia | High altitude, pulmonary oedema, PE, pneumonia |
| Iatrogenic | Mechanical over-ventilation (high RR/TV) |
| CNS stimulation | Cerebral oedema, meningitis, stroke |
| Metabolic | Liver failure (NH3), sepsis, thyrotoxicosis |
| GCC-specific | Pregnancy (progesterone), heat exhaustion |
↑ RR → ↓ PaCO2 → respiratory alkalosis risk. Target RR 12–20/min. In COPD allow permissive hypercapnia (pH >7.25).
Lung-protective: 6 mL/kg IBW. High TV causes hypocapnia + barotrauma. Low TV causes CO2 retention.
PEEP recruits alveoli → improves V/Q matching → reduces hypoxic respiratory drive. Does not directly alter PaCO2.
Driving pressure = Plateau P – PEEP. Target <15 cmH2O. High driving pressure = lung injury risk, worsens acidosis.
In ARDS: accept PaCO2 up to 60–80 mmHg (pH >7.2) to limit lung injury. Contraindicated in raised ICP.
pH 7.35–7.45, PaCO2 near baseline, RR <25, RSBI <105, minimal pressure support (<8 cmH2O).
Or if albumin in g/L: AG + 0.25 × (40 − measured albumin). Every 10 g/L drop in albumin reduces AG by ~2.5 mEq/L — hypoalbuminaemia masks high AG acidosis in ICU patients.
| Letter | Cause | Key Feature |
|---|---|---|
| M | Methanol | Visual disturbance, osmolar gap |
| U | Uraemia | Renal failure, ↑ creatinine |
| D | Diabetic Ketoacidosis | Ketonuria, hyperglycaemia, ↑ ketones |
| P | Propylene glycol | IV medications (lorazepam), osmolar gap |
| I | Isoniazid / Ibuprofen | Drug history, seizures (INH) |
| L | Lactic acidosis | ↑ Lactate >2 mmol/L |
| E | Ethylene glycol | Antifreeze ingestion, oxalate crystals in urine |
| S | Salicylates | Aspirin OD, mixed resp. alkalosis + met. acidosis |
| Letter | Cause |
|---|---|
| U | Ureteral diversion (ileal conduit) |
| S | Saline excess (hyperchloraemic acidosis) |
| E | Extra-renal HCO3- loss (pancreatic fistula) |
| D | Diarrhoea (HCO3- lost in stool) |
| C | CARbonic anhydrase inhibitors (acetazolamide) |
| A | Adrenal insufficiency |
| R | Renal tubular acidosis (Types 1, 2, 4) |
| P | Post-hypocapnia (correction of chronic resp. alkalosis) |
| Cause | Mechanism |
|---|---|
| Vomiting / NG suction | Loss of HCl → net HCO3- gain |
| Diuretics (loop/thiazide) | Cl- and K+ loss → contraction alkalosis |
| Post-hypercapnia | Renal HCO3- retention persists after CO2 correction |
| Cause | Note |
|---|---|
| Primary hyperaldosteronism | Conn's syndrome — HTN + hypokalaemia |
| Cushing's syndrome | Cortisol excess → mineralocorticoid effect |
| Bartter/Gitelman syndrome | Tubular channel defects |
| Exogenous steroids | High-dose corticosteroids |
If actual PaCO2 > expected → additional respiratory acidosis. If actual PaCO2 < expected → additional respiratory alkalosis (mixed disorder).
Compensation is usually incomplete — body doesn't hypoventilate to the point of significant hypoxia.
| Disorder | Expected Compensation | Timeframe |
|---|---|---|
| Metabolic Acidosis | PaCO2 = (1.5 × HCO3-) + 8 ± 2 (Winter's) | 12–24 hours |
| Metabolic Alkalosis | PaCO2 = (0.7 × HCO3-) + 21 ± 2 | 24–36 hours |
| Acute Resp. Acidosis | HCO3- = 24 + (PaCO2 − 40) / 10 | Minutes |
| Chronic Resp. Acidosis | HCO3- = 24 + (PaCO2 − 40) × 3.5 / 10 | 3–5 days |
| Acute Resp. Alkalosis | HCO3- = 24 − (40 − PaCO2) × 2 / 10 | Minutes |
| Chronic Resp. Alkalosis | HCO3- = 24 − (40 − PaCO2) × 5 / 10 | 3–5 days |
Used when AG metabolic acidosis is present. Compares expected vs actual HCO3- fall to detect a second metabolic disorder.
| Ratio | Interpretation | Clinical Meaning |
|---|---|---|
| <0.4 | Non-AG acidosis coexists | Concurrent hyperchloraemic acidosis (e.g. diarrhoea + DKA) |
| 0.4–1.0 | Mixed: High AG + Non-AG acidosis | Both types contributing |
| 1.0–2.0 | Pure high AG metabolic acidosis | Expected — no mixed disorder |
| >2.0 | Metabolic alkalosis coexists | Concurrent vomiting + lactic acidosis |
| Pattern | Example | ABG Clue |
|---|---|---|
| Met. Acidosis + Resp. Alkalosis | Sepsis, salicylate OD | pH may appear normal; both HCO3- ↓ and PaCO2 ↓ |
| Met. Acidosis + Resp. Acidosis | Cardiac arrest | Very low pH; inadequate compensation |
| Met. Alkalosis + Resp. Acidosis | COPD + vomiting | Normal or near-normal pH; high HCO3- + high PaCO2 |
| Met. Alkalosis + Resp. Alkalosis | Liver failure + NG suction | Very high pH; both HCO3- ↑ and PaCO2 ↓ |
| Triple disorder | Alcoholic ketoacidosis + vomiting + resp. alkalosis | Complex — requires delta-delta + full history |
High anion gap metabolic acidosis due to accumulation of beta-hydroxybutyrate and acetoacetate. AG typically 20–30+.
| Priority | Action | Acid-Base Effect |
|---|---|---|
| 1 | IV fluids (0.9% NaCl then 0.45%) | Restores renal perfusion → ↑ ketone excretion |
| 2 | Insulin infusion (0.1 U/kg/hr) | Suppresses lipolysis → closes AG |
| 3 | K+ replacement | Prevents hypokalaemia from insulin/correction |
| 4 | Monitor ABGs q2–4h | Track AG closure — target AG <12 |
Anaerobic metabolism due to inadequate O2 delivery. Lactate >2 mmol/L (significant >4 mmol/L).
| Cause | Management |
|---|---|
| Septic shock | Fluids, antibiotics, vasopressors |
| Cardiogenic shock | Inotropes, revascularisation |
| Haemorrhage | Blood products, surgery |
| Mesenteric ischaemia | Urgent surgical review |
| Cause | Note |
|---|---|
| Metformin toxicity | Inhibits mitochondrial complex 1; CRRT if severe |
| Liver failure | Reduced lactate clearance; transplant consideration |
| Malignancy | Warburg effect (aerobic glycolysis) |
| HIV medications | Nucleoside analogues — mitochondrial toxicity |
| Thiamine deficiency | Pyruvate dehydrogenase inhibition — IV thiamine |
| Type | Name | Defect | K+ | Urine pH | Key Associations |
|---|---|---|---|---|---|
| Type 1 | Distal RTA | Failure to excrete H+ in distal tubule | ↓ Hypokalaemia | >5.5 | Nephrolithiasis, nephrocalcinosis, Sjögren's, amphotericin B |
| Type 2 | Proximal RTA | Failure to reabsorb HCO3- in proximal tubule | ↓ Hypokalaemia | Variable | Fanconi syndrome, myeloma, carbonic anhydrase inhibitors, Wilson's disease |
| Type 4 | Hyperkalaemic RTA | Hypoaldosteronism → reduced NH3 excretion | ↑ Hyperkalaemia | <5.5 | Diabetes, ACE inhibitors, spironolactone, Addison's, obstructive uropathy |
| Fluid | Cl- content | Acid-Base Effect |
|---|---|---|
| 0.9% NaCl (Normal Saline) | 154 mEq/L | Causes hyperchloraemic acidosis |
| Hartmann's (Ringer's Lactate) | 111 mEq/L | Balanced — metabolised to HCO3- |
| PlasmaLyte | 98 mEq/L | Best balance — gluconate/acetate |
| 5% Dextrose | 0 | No Cl- load but no volume support |
pH <7.35 = acidaemia | pH >7.45 = alkalaemia | pH 7.35–7.45 = normal (but may still have a disorder)
Look at PaCO2 and HCO3-. If pH ↓ and PaCO2 ↑ → Respiratory Acidosis. If pH ↓ and HCO3- ↓ → Metabolic Acidosis. Apply same logic for alkalosis.
Apply compensation formulae. If actual value matches expected → appropriate (simple disorder). If not → mixed disorder.
AG = Na − (Cl + HCO3-). If >12 → high AG. Correct for albumin. Classify as MUDPILES or USED CARP.
DD = (AG−12)/(24−HCO3-). <0.4 = additional non-AG acidosis. >2 = additional metabolic alkalosis. 1–2 = pure high AG acidosis.
Osmolar gap elevated. Visual disturbance "snowstorm blindness". Treat: fomepizole, dialysis.
CKD/AKF. Accumulation of organic acids (sulfate, phosphate). Treat: dialysis, conservative management.
Beta-hydroxybutyrate + acetoacetate. Urine ketones +. Glucose usually >11 mmol/L. Insulin + fluids.
Solvent in IV lorazepam/diazepam. Osmolar gap. Seen in ICU with prolonged infusions. Stop medication.
Isoniazid: seizures + lactic acidosis. Ibuprofen overdose rare cause. Drug history essential.
Type A (hypoperfusion) or Type B (metformin, malignancy). Lactate >4 mmol/L = severe. Treat cause.
Antifreeze. Oxalate crystals in urine. Osmolar gap. Treat: fomepizole, ethanol infusion, dialysis.
Aspirin OD. Mixed high AG metabolic acidosis + respiratory alkalosis (direct stimulation of resp. centre). Urine alkalinisation + dialysis if severe.
Extreme heat → hyperventilation → respiratory alkalosis (PaCO2 ↓, pH ↑). If severe/prolonged: dehydration → ↓ perfusion → lactic acidosis (mixed disorder). Heatstroke: combined high AG metabolic acidosis + multi-organ failure.
Prolonged fasting (16–18h): mild ketonaemia → slight AG elevation. Dehydration → ↓ renal HCO3- excretion → relative alkalosis. Diabetic patients: high risk of DKA. Hypoglycaemia in insulin-dependent patients → lactic acidosis risk.
| Disorder | pH | PaCO2 | HCO3- | Mnemonic |
|---|---|---|---|---|
| Resp. Acidosis | ↓ | ↑ | ↑ (comp) | COPD, OHS, opioids |
| Resp. Alkalosis | ↑ | ↓ | ↓ (comp) | Anxiety, pregnancy, liver failure |
| Met. Acidosis | ↓ | ↓ (comp) | ↓ | MUDPILES / USED CARP |
| Met. Alkalosis | ↑ | ↑ (comp) | ↑ | Vomiting, diuretics, Conn's |